Citation: | Houfang Long, Shuyi Zeng, Dan Li. Cellular and animal models to investigate pathogenesis of amyloid aggregation in neurodegenerative diseases[J]. Biophysics Reports, 2022, 8(1): 14-28. doi: 10.52601/bpr.2022.210033 |
[1] |
Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351(3): 602−611 doi: 10.1016/j.bbrc.2006.10.093
|
[2] |
Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152(4): 879−884
|
[3] |
Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122 ( Pt 8): 1437-1448
|
[4] |
Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci USA 85(11): 4051−4055 doi: 10.1073/pnas.85.11.4051
|
[5] |
Li Y, Zhao C, Luo F, Liu Z, Gui X, Luo Z, Zhang X, Li D, Liu C, Li X (2018) Amyloid fibril structure of alpha-synuclein determined by cryo-electron microscopy. Cell Res 28(9): 897−903 doi: 10.1038/s41422-018-0075-x
|
[6] |
Long H, Zheng W, Liu Y, Sun Y, Zhao K, Liu Z, Xia W, Lv S, Liu Z, Li D, He KW, Liu C (2021) Wild-type alpha-synuclein inherits the structure and exacerbated neuropathology of E46K mutant fibril strain by cross-seeding. Proc Natl Acad Sci USA 118(20): e2012435118. https://doi.org/10.1073/pnas.2012435118
|
[7] |
Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, Lee VM (2012) Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109): 949−953 doi: 10.1126/science.1227157
|
[8] |
Luk KC, Song C, O'Brien P, Stieber A, Branch JR, Brunden KR, Trojanowski JQ, Lee VM (2009) Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci USA 106(47): 20051−20056 doi: 10.1073/pnas.0908005106
|
[9] |
Murphy MP, LeVine H, 3rd (2010) Alzheimer's disease and the amyloid-beta peptide. J Alzheimers Dis 19(1): 311−323 doi: 10.3233/JAD-2010-1221
|
[10] |
Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645): 839−840 doi: 10.1038/42166
|
[11] |
Volpicelli-Daley LA, Luk KC, Lee VM (2014) Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc 9(9): 2135−2146 doi: 10.1038/nprot.2014.143
|
[12] |
Zhang B, Kehm V, Gathagan R, Leight SN, Trojanowski JQ, Lee VM, Luk KC (2019) Stereotaxic Targeting of Alpha-Synuclein Pathology in Mouse Brain Using Preformed Fibrils. Methods Mol Biol 1948: 45−57
|